KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.82 $19.54 Friday, 26th Apr 2024 MGNX stock ended at $14.56. This is 1.32% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 7.31% from a day low at $14.22 to a day high of $15.26.
90 days $12.82 $21.88
52 weeks $4.29 $21.88

Historical MacroGenics prices

Date Open High Low Close Volume
Mar 07, 2016 $18.42 $19.49 $17.80 $19.47 311 600
Mar 04, 2016 $17.53 $18.73 $16.92 $18.61 498 400
Mar 03, 2016 $17.05 $17.27 $16.52 $17.14 329 100
Mar 02, 2016 $16.70 $17.71 $16.27 $17.08 418 800
Mar 01, 2016 $15.91 $16.67 $15.00 $16.63 467 900
Feb 29, 2016 $15.77 $16.52 $15.53 $15.98 354 900
Feb 26, 2016 $15.41 $16.14 $15.01 $15.82 276 900
Feb 25, 2016 $15.93 $16.27 $15.01 $15.28 233 900
Feb 24, 2016 $15.48 $15.98 $14.85 $15.74 246 100
Feb 23, 2016 $17.42 $17.49 $15.68 $15.69 211 100
Feb 22, 2016 $17.94 $18.41 $17.41 $17.51 222 000
Feb 19, 2016 $16.96 $17.51 $16.29 $17.42 236 500
Feb 18, 2016 $18.03 $18.44 $17.10 $17.15 305 900
Feb 17, 2016 $17.06 $18.30 $16.89 $17.54 319 600
Feb 16, 2016 $16.64 $17.53 $16.21 $16.88 250 600
Feb 12, 2016 $15.66 $16.50 $15.08 $16.38 219 700
Feb 11, 2016 $15.65 $16.06 $14.84 $15.30 368 600
Feb 10, 2016 $16.36 $17.38 $15.83 $16.06 207 400
Feb 09, 2016 $15.87 $16.83 $15.52 $16.21 236 300
Feb 08, 2016 $17.91 $18.23 $15.70 $16.21 400 800
Feb 05, 2016 $18.97 $19.65 $17.97 $18.23 331 300
Feb 04, 2016 $18.50 $20.44 $18.19 $19.18 207 600
Feb 03, 2016 $19.85 $19.90 $17.62 $18.53 302 600
Feb 02, 2016 $20.34 $20.49 $19.48 $19.70 202 300
Feb 01, 2016 $20.03 $21.02 $19.24 $20.64 216 600
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT